Smart Insulin Pens Market Size- By Product, By Connectivity Type, By Application, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
세계 스마트 인슐린 펜 시장 규모는 2033년까지 10.69%의 연평균 복합 성장률(CAGR)로 20억 5,411만 달러 규모로 성장할 것으로 예상됩니다.
코로나19로 인해 병원과 당뇨병 센터를 방문하는 환자가 줄어들면서 스마트 인슐린 펜 처방이 감소했습니다. 또한, 유통망 문제로 인해 소매점에서의 구매가 어려워져 판매량이 감소했습니다. 코로나19와 관련된 경기 침체로 인해 소비자들의 비용에 대한 인식이 높아지면서 고가의 인슐린 펜 시장이 축소되었습니다.
세계 스마트 인슐린 펜(Smart Insulin Pen) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 시장 역학
- 성장 촉진요인 및 억제요인, 기회, 과제 분석
- 시장에 대한 COVID-19의 영향
제5장 시장 변수와 전망
- SWOT 분석
- PESTEL 분석
- Porter의 Five Forces 분석
- 히트맵 분석
제6장 경쟁 구도
- 제조거점 분포·판매 지역·제품 유형
- 인수합병(M&A)·제휴·제품 발매·협력
제7장 세계의 스마트 인슐린 펜 시장 : 제품별
- 세계 시장 규모 점유율·예측
- 스마트 인슐린 펜
- 기존 펜용 어댑터
제8장 세계의 스마트 인슐린 펜 시장 : 접속 유형별
- 세계 시장 규모 점유율·예측
- Bluetooth
- USB
제9장 세계의 스마트 인슐린 펜 시장 : 용도별
- 세계 시장 규모 점유율·예측
- 1형 당뇨병
- 2형 당뇨병
제10장 세계의 스마트 인슐린 펜 시장 : 유통 채널별
- 세계 시장 규모 점유율·예측
- 병원 약국
- 온라인 판매
- 소매 약국
- 당뇨병 클리닉/센터
제11장 세계의 스마트 인슐린 펜 시장 예측
제12장 세계의 스마트 인슐린 펜 시장 : 제품 유형별
제13장 세계의 스마트 인슐린 펜 시장 : 접속 유형별
제14장 세계의 스마트 인슐린 펜 시장 : 용도별
제15장 세계의 스마트 인슐린 펜 시장 : 유통 채널별
제16장 세계의 스마트 인슐린 펜 시장 : 지역별
- 시장 규모·시장 점유율 추이·예측
- 아시아태평양
- 유럽
- 중동 및 아프리카
- 북미
- 라틴아메리카
제17장 기업 개요
- Bigfoot Biomedical
- Diamesco Co. Ltd.
- Eli Lilly and Company
- Emperra GmbH
- Jiangsu Deflu Medical Device Co. Ltd.
- Medtronic plc
- Novo Nordisk A/S
- Pendiq
- Sanofi(Sanofi-Aventis US LLC)
- Ypsomed Holding AG
- 기타
제18장 약어 리스트
제19장 참고 링크
제20장 결론
제21장 조사 범위
LSH
Smart Insulin Pens Market Introduction and Overview
According to SPER market research, Smart Insulin Pens Market Size- By Product, By Connectivity Type, By Application, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Smart Insulin Pens Market is predicted to reach USD 2054.11 Million by 2033 with a CAGR of 10.69%.
Smart insulin pens provide an accessible option for exogenous insulin administration and diabetes treatment. It is a reusable injector pen that works with a simple app on a smartphone which allow for wireless data transfer to the app. This intelligent system keeps track of dosages and generates reports, useful notifications, and half-unit doses that are exact. In addition, it alerts patients whenever insulin is about to expire or reaches its temperature spectrum, allowing them to change the cartridge and provide diabetic information to the medical staff as needed.
There was a decrease in the number of prescriptions for smart insulin pens as a result of fewer patients visiting hospitals and diabetic centers during the COVID 19 pandemic. Additionally, the accessibility of these pens at retail stores was disrupted by problems in the delivery chain, which led to a decrease in sales. The pandemic-related economic slowdown made consumers more cost-conscious, which decreased the market for expensive connected insulin pens.
Scope of the Report:
Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Product, By Connectivity Type, By Application, By Distribution Channel
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Bigfoot Biomedical, Diamesco Co. Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, Pendiq, Sanofi (Sanofi-Aventis US LLC), Ypsomed Holding AG, and others.
Smart Insulin Pens Market Segmentation
By Product: Based on the Product, Global Smart Insulin Pens Market is segmented as; Smart Insulin Pens, Adaptors for Conventional Pens
By Application: Based on the Application, Global Smart Insulin Pens Market is segmented as; Type 1 Diabetes, Type 2 Diabetes
By Distribution Channel: Based on the Distribution Channel, Global Smart Insulin Pens Market is segmented as; Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics/Centers
Table of Contents
1.Introduction
- 1.1.Scope of the report
- 1.2.Market segment analysis
2.Research Methodology
- 2.1.Research data source
- 2.1.1.Secondary Data
- 2.1.2.Primary Data
- 2.1.3.SPER's internal database
- 2.1.4.Premium insight from KOL's
- 2.2.Market size estimation
- 2.2.1.Top-down and Bottom-up approach
- 2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
- 4.1.Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1.Drivers
- 4.1.2.Restraints
- 4.1.3.Opportunities
- 4.1.4.Challenges
- 4.2.COVID-19 Impacts of the Global Smart Insulin Pens Market
5.Market variable and outlook
- 5.1.SWOT Analysis
- 5.1.1.Strengths
- 5.1.2.Weaknesses
- 5.1.3.Opportunities
- 5.1.4.Threats
- 5.2.PESTEL Analysis
- 5.2.1.Political Landscape
- 5.2.2.Economic Landscape
- 5.2.3.Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5.Environmental Landscape
- 5.2.6.Legal Landscape
- 5.3.PORTER's Five Forces
- 5.3.1.Bargaining power of suppliers
- 5.3.2.Bargaining power of buyers
- 5.3.3.Threat of Substitute
- 5.3.4.Threat of new entrant
- 5.3.5.Competitive rivalry
- 5.4.Heat Map Analysis
6.Competitive Landscape
- 6.1.Global Smart Insulin Pens Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Smart Insulin Pens Market
7.Global Smart Insulin Pens Market, By Product (USD Million)
- 7.1.Global Smart Insulin Pens Market Value Share and Forecast, By Product, 2024-2033
- 7.2.Smart Insulin Pens
- 7.3.Adaptors for Conventional Pens
8.Global Smart Insulin Pens Market, By Connectivity Type (USD Million)
- 8.1.Global Smart Insulin Pens Market Value Share and Forecast, By Connectivity Type, 2024-2033
- 8.2.Bluetooth
- 8.3.USB
9.Global Smart Insulin Pens Market, By Application (USD Million)
- 9.1.Global Smart Insulin Pens Market Value Share and Forecast, By Application, 2024-2033
- 9.2.Type 1 Diabetes
- 9.3.Type 2 Diabetes
10.Global Smart Insulin Pens Market, By Distribution Channel (USD Million)
- 10.1.Global Smart Insulin Pens Market Value Share and Forecast, By Distribution Channel, 2024-2033
- 10.2.Hospital Pharmacies
- 10.3.Online Sales
- 10.4.Retail Pharmacies
- 10.5.Diabetes Clinics/Centers
11.Global Smart Insulin Pens Market Forecast, 2020-2033 (USD Million)
- 11.1.Global Smart Insulin Pens Market Size and Market Share
12.Global Smart Insulin Pens Market, By Product Type 2020-2033 (USD Million)
- 12.1.Global Smart Insulin Pens Market Size and Market Share By Product (2020-2026)
- 12.2.Global Smart Insulin Pens Market Size and Market Share By Product (2027-2033)
13.Global Smart Insulin Pens Market, By Connectivity Type, 2020-2033 (USD Million)
- 13.1.Global Smart Insulin Pens Market Size and Market Share By Connectivity Type (2020-2026)
- 13.2.Global Smart Insulin Pens Market Size and Market Share By Connectivity Type (2027-2033)
14.Global Smart Insulin Pens Market, By Application, 2020-2033 (USD Million)
- 14.1.Global Smart Insulin Pens Market Size and Market Share By Application (2020-2026)
- 14.2.Global Smart Insulin Pens Market Size and Market Share By Application (2027-2033)
15.Global Smart Insulin Pens Market, By Distribution Channel, 2020-2033 (USD Million)
- 15.1.Global Smart Insulin Pens Market Size and Market Share By Distribution Channel (2020-2026)
- 15.2.Global Smart Insulin Pens Market Size and Market Share By Distribution Channel (2027-2033)
16.Global Smart Insulin Pens Market, By Region, 2020-2033 (USD Million)
- 16.1.Global Smart Insulin Pens Market Size and Market Share By Region (2020-2026)
- 16.2.Global Smart Insulin Pens Market Size and Market Share By Region (2027-2033)
- 16.3.Asia-Pacific
- 16.3.1.Australia
- 16.3.2.China
- 16.3.3.India
- 16.3.4.Japan
- 16.3.5.South Korea
- 16.3.6.Rest of Asia-Pacific
- 16.4.Europe
- 16.4.1.France
- 16.4.2.Germany
- 16.4.3.Italy
- 16.4.4.Spain
- 16.4.5.United Kingdom
- 16.4.6.Rest of Europe
- 16.5.Middle East and Africa
- 16.5.1.Kingdom of Saudi Arabia
- 16.5.2.United Arab Emirates
- 16.5.3.Rest of Middle East & Africa
- 16.6.North America
- 16.6.1.Canada
- 16.6.2.Mexico
- 16.6.3.United States
- 16.7.Latin America
- 16.7.1.Argentina
- 16.7.2.Brazil
- 16.7.3.Rest of Latin America
17.Company Profile
- 17.1.Bigfoot Biomedical
- 17.1.1.Company details
- 17.1.2.Financial outlook
- 17.1.3.Product summary
- 17.1.4.Recent developments
- 17.2.Diamesco Co. Ltd.
- 17.2.1.Company details
- 17.2.2.Financial outlook
- 17.2.3.Product summary
- 17.2.4.Recent developments
- 17.3.Eli Lilly and Company
- 17.3.1.Company details
- 17.3.2.Financial outlook
- 17.3.3.Product summary
- 17.3.4.Recent developments
- 17.4.Emperra GmbH
- 17.4.1.Company details
- 17.4.2.Financial outlook
- 17.4.3.Product summary
- 17.4.4.Recent developments
- 17.5.Jiangsu Deflu Medical Device Co. Ltd.
- 17.5.1.Company details
- 17.5.2.Financial outlook
- 17.5.3.Product summary
- 17.5.4.Recent developments
- 17.6.Medtronic plc
- 17.6.1.Company details
- 17.6.2.Financial outlook
- 17.6.3.Product summary
- 17.6.4.Recent developments
- 17.7.Novo Nordisk A/S
- 17.7.1.Company details
- 17.7.2.Financial outlook
- 17.7.3.Product summary
- 17.7.4.Recent developments
- 17.8.Pendiq
- 17.8.1.Company details
- 17.8.2.Financial outlook
- 17.8.3.Product summary
- 17.8.4.Recent developments
- 17.9.Sanofi (Sanofi-Aventis US LLC)
- 17.9.1.Company details
- 17.9.2.Financial outlook
- 17.9.3.Product summary
- 17.9.4.Recent developments
- 17.10.Ypsomed Holding AG
- 17.10.1.Company details
- 17.10.2.Financial outlook
- 17.10.3.Product summary
- 17.10.4.Recent developments
- 17.11.Others
18.List of Abbreviations
19.Reference Links
20.Conclusion
21.Research Scope
